摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[6-(N-(n-butyl)carbamoyl]-2-[4-(N-(n-butyl)carbamoyl)phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl] methanone

中文名称
——
中文别名
——
英文名称
[6-(N-(n-butyl)carbamoyl]-2-[4-(N-(n-butyl)carbamoyl)phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl] methanone
英文别名
[6-(N-(n-butyl)carbamoyl]-2-[4-[N-(n-butyl)carbamoyl]phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone;[6-(N-n-butylcarbamoyl]-2-[4-(N-n-butylcarbamoyl)phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]-phenyl] methanone;N-butyl-2-[4-(butylcarbamoyl)phenyl]-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophene-6-carboxamide
[6-(N-(n-butyl)carbamoyl]-2-[4-(N-(n-butyl)carbamoyl)phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl] methanone化学式
CAS
——
化学式
C38H45N3O4S
mdl
——
分子量
639.859
InChiKey
BOWZFFKVQAZDFB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.9
  • 重原子数:
    46
  • 可旋转键数:
    15
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    116
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    雷洛昔芬异氰酸正丁酯氯仿 、 silica gel 、 chloroform methanol 作用下, 以 四氢呋喃 为溶剂, 反应 72.0h, 以to afford 4.87 g of the title compound as a tan amorphous powder的产率得到[6-(N-(n-butyl)carbamoyl]-2-[4-(N-(n-butyl)carbamoyl)phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl] methanone
    参考文献:
    名称:
    Methods of treating neuropeptide Y-associated conditions
    摘要:
    本发明描述了治疗与神经肽Y过量相关的疾病的方法,包括给予肥胖蛋白的类似物。本发明进一步描述了治疗与神经肽Y过量相关的疾病的方法,包括给予肥胖蛋白的类似物和神经肽Y拮抗剂的组合。本发明证明肥胖蛋白通过减少下丘脑产生神经肽Y的作用。
    公开号:
    US06221838B1
点击查看最新优质反应信息

文献信息

  • Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
    申请人:Eli Lilly and Company
    公开号:US05482949A1
    公开(公告)日:1996-01-09
    The present invention relates to sulfonate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.
    本发明涉及3-芳酰基苯并[b]噻吩的磺酸盐衍生物,含有这些化合物的制药配方以及使用这些化合物来抑制骨质流失、降低血清胆固醇水平和治疗激素依赖性哺乳动物乳腺和子宫癌的方法。
  • Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes
    申请人:Eli Lilly and Company
    公开号:US05605924A1
    公开(公告)日:1997-02-25
    The present invention relates to compounds of the formula ##STR1## where X is a bond or --CH2--; R.sup.2 is pyrrolidino; R is OH, --OSO.sub.2 --(CH.sub.2).sub.n --CH.sub.3 or ##STR2## R.sup.1 is hydrogen, OH, fluoro, chloro, --OSO.sub.2 --(CH.sub.2).sub.n --CH.sub.3 or ##STR3## each R.sup.3 is independently C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, unsubstituted or substituted phenyl where the substituent is fluoro, chloro, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy; each n is independently 3, 4 or 5; and pharmaceutically acceptable salts and solvates thereof; provided that at least one of R and R.sup.1 is ##STR4## The invention also relates to methods of use of the compounds of formula I and pharmaceutical compositions which comprise compounds of formula I.
    本发明涉及式为##STR1##的化合物,其中X为键或--CH2--; R.sup.2为吡咯烷基; R为OH,--OSO.sub.2 --(CH.sub.2).sub.n --CH.sub.3或##STR2## R.sup.1为氢,OH,氟,氯,--OSO.sub.2 --(CH.sub.2).sub.n --CH.sub.3或##STR3##每个R.sup.3独立地为C.sub.1 -C.sub.6烷基,C.sub.3 -C.sub.6环烷基,未取代或取代苯基,其中取代基为氟,氯,C.sub.1 -C.sub.3烷基或C.sub.1 -C.sub.3烷氧基;每个n独立地为3,4或5;以及其药学上可接受的盐和溶剂合物; 前提是R和R.sup.1中至少有一个为##STR4## 本发明还涉及使用式I化合物的方法和包含式I化合物的药物组合物。
  • Carbamate derivatives of 3-aroylbenzo[b] thiophenes
    申请人:Eli Lilly and Company
    公开号:US05994371A1
    公开(公告)日:1999-11-30
    The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.
    本发明涉及3-芳香基苯并噻吩的磺酸盐和氨基甲酸酯衍生物,包含这些化合物的药物配方以及使用这些化合物抑制骨质流失、降低血清胆固醇水平和治疗激素依赖性哺乳动物乳腺和子宫癌的方法。
  • Sulfonate and carbamate derivatives of 3-aroylbenzo\x9bb!thiophenes
    申请人:Eli Lilly and Company
    公开号:US05798351A1
    公开(公告)日:1998-08-25
    The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo\x9bb!thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.
    本发明涉及3-芳酰基苯并[b]噻吩的磺酸盐和氨基甲酸酯衍生物,含有这些化合物的制药配方以及使用这些化合物抑制骨质流失、降低血清胆固醇水平和治疗激素依赖性哺乳动物乳腺和子宫癌的方法。
  • Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes
    申请人:ELI LILLY AND COMPANY
    公开号:EP0617030A1
    公开(公告)日:1994-09-28
    The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.
    本发明涉及 3-芳基苯并[b]噻吩的磺酸盐和氨基甲酸酯衍生物、含有这些化合物的药物制剂以及使用这类化合物抑制骨质流失、降低血清胆固醇水平和治疗激素依赖性哺乳动物乳腺癌和子宫癌的方法。
查看更多